SCHEMBL9316142

SCHEMBL9316142

CCOC(=O)C=Cc1cc2cc(CC)ccc2o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.48
CA2 P00918 3/20 0.48
CA7 P43166 3/20 0.48
CA9 Q16790 3/20 0.48
CA14 Q9ULX7 3/20 0.48
CA3 P07451 2/20 0.48
CA6 P23280 2/20 0.48
CA5B Q9Y2D0 2/20 0.48
CA4 P22748 1/20 0.48
CYP3A4 P08684 2/20 0.45
NPC1 O15118 1/20 0.45
CASP3 P42574 1/20 0.45
RAB9A P51151 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
PTGS2 P35354 1/20 0.44
TTR P02766 1/20 0.43
DPP4 P27487 1/20 0.43
MAOB P27338 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9316110 0.87 APP (0.47) CA12CA2CA7CA9CA14
SCHEMBL9315711 0.85 ALDH1A1 (0.47) CA12CA2CA7CA9CA14
SCHEMBL9315954 0.85 APP (0.47) CA12CA2CA7CA9CA14
SCHEMBL9316714 0.85 CYP2A6 (0.51) CA12CA2CA7CA9CA14
SCHEMBL9110298 0.83 CYP3A4 (0.62) CA12CA2CA7CA9CA14
SCHEMBL9110304 0.83 CYP3A4 (0.62) CA12CA2CA7CA9CA14
SCHEMBL9316719 0.82 CYP3A4 (0.43) CA12CA2CA7CA9CA14
SCHEMBL9316107 0.81 CYP3A4 (0.42) CA12CA2CA7CA9CA14
SCHEMBL8328098 0.79 CA12 (0.50) CA12CA2CA7CA9CA14
SCHEMBL25777700 0.76 CA12 (0.59) CA12CA2CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed